Navigation Links
Ceremed Appoints Vice President for Sales and Business Development
Date:2/22/2008

LOS ANGELES, Feb. 22 /PRNewswire/ -- Ceremed, Inc., a medical device corporation, announced today that it has appointed Mr. Anthony Ruggiero as its new Vice President for Sales and Business Development. Mr. Ruggiero will join Ceremed and its affiliate corporation, Bioplate, Inc. at their Los Angeles corporate headquarters to direct global sales and strategic business development operations for both companies. He will assume his responsibilities on February 25th.

Mr. Ruggiero comes to Ceremed from Invibio, a biomaterials subsidiary of Victrex USA, where he served as the Americas and Asia Pacific Commercial Director. He was instrumental in developing Invibio's market for PEEK-OPTIMA, an implantable polymer material used in a variety of medical applications, including orthopedic and neurosurgical procedures. "We believe the combination of Mr. Ruggiero's market expertise, his established contacts with market leaders, and Ceremed's unique technology should allow him to create a substantial market for our company's new polymer products due to be launched this Spring," said Tadeusz Wellisz, M.D., President of Ceremed.

The planned launch of porous polyethylene maxillofacial implants coated with Ceremed's proprietary soluble Alkylene Oxide Copolymers (AOC) should benefit immediately from Mr. Ruggiero's industry connections and product knowledge. "The coating of the Porous Polyethylene (PPE) products with the AOC component will address the tissue grab problem, which currently limits the usefulness of existing products," said Dr. Wellisz. Other products planned for release include a line of AOC-coated porous metal implants designed to improve the ease of handling and application of the implants when they come into contact with human tissue.

"I very much look forward to bringing my experience and skills to Ceremed," said Mr. Ruggiero. "The company's cutting-edge technology has the potential to revolutionize the wound management and implant market. Alkylene Oxide Copolymers open tremendous possibilities in the development of soluble delivery systems for various therapeutic agents, from antibiotics to bone growth factors. I am very excited about the opportunity to make Ceremed's innovative products available to surgeons and their patients."

About the company:

Ceremed, Inc. is a privately held medical device corporation formed in 2002 by a surgeon and a group of scientists from the University of Southern California. The company has unique expertise and a portfolio of innovative proprietary technology in the field of soluble alkylene oxide copolymers. These polymers have multiple medical applications, including bone hemostasis and delivery system for a variety of therapeutic agents.

For additional information about the Company, please contact Danielle Nolan at 310-815-2125 or info@ceremed.com.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Tadeusz Wellisz http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=72918


'/>"/>
SOURCE Ceremed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
2. Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
3. AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors
4. Natural Alternatives International, Inc. Appoints New Chief Financial Officer
5. Deerfield Spa Appoints New Fitness Director
6. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
7. P\S\L Group appoints Paul Barnes as Group President P\S\L Research
8. AtriCure Appoints Mark A. Collar to its Board of Directors
9. Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
10. Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
11. Skinvisible Appoints New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: